This Doctor Used His Math Skills

Working With Doctors Who Lean on Quantitative Methods

I run into this fairly often in practice. You have a physician who has a background in engineering, statistics, or straight-up mathematics, and they approach clinical problems the way an actuary would. The result is either brilliant or completely off the rails. There is not much in between. When this doctor used his math skills on a dosing optimization problem back in 2019, we ended up cutting average time-to-therapeutic-level by roughly forty percent on a small cohort of patients with renal impairment. That was the high point. The low point came three months later when he tried to apply the same Bayesian framework to risk stratification for sepsis onset, and the model started flagging healthy patients because the training data had a hidden confounder we missed. Took us six weeks to debug. I still see the dashboard on occasion.

What It Looks Like When This Doctor Used His Math Skills

The core idea is straightforward enough. A clinician with quantitative training treats a medical question as an optimization or estimation problem rather than a purely heuristic one. They build models. They run simulations. They validate against historical data before putting anything near a patient workflow. Here is how the workflow actually plays out in a real hospital environment, not the textbook version: Step one is data collection and cleaning. Most people skip this or treat it as somebody else's job. The person doing the math needs raw, timestamped data. Labs, vitals, medication administration records, outcome flags. If your EHR export is missing timestamps on nursing assessments, the model is already wrong. We spent two days just reconciling med admin times between the smart pump logs and the paper flow sheets. They did not match. Ever.

Step two is defining the objective function. What are you actually optimizing? This is where most attempts fail. A doctor might want to "reduce adverse drug events" but that is not a single number you can minimize. You need to pick one: mortality, length of stay, time to clinical improvement, readmission rate. Pick one. You can add others as constraints later. Step three is choosing the right method. Linear regression for simple relationships. Time-series models for sequential data like vitals. Survival analysis for time-to-event outcomes. Reinforcement learning if you are doing dynamic treatment regime optimization, which is still mostly research-grade at this point and I would not recommend pushing it into production without a serious validation pipeline. Step four is validation before deployment. Hold out a portion of your data. Cross-validate. Check for overfitting. Then run a prospective pilot with a safety net — meaning a human reviews every recommendation before it touches a patient. We learned this the hard way after the sepsis model incident. Now we never deploy without a shadow mode period of at least thirty days where the model runs silently and its predictions are logged but never shown.

Step five is monitoring after deployment. Model performance degrades. Patient populations shift. New treatment protocols change the baseline. We check our key metrics monthly. If drift exceeds five percent from the validation baseline, we pause and retrain.

The Parts Nobody Talks About

Model interpretability is a real constraint in medicine. A black-box model that predicts correctly but cannot explain why will get rejected by any institutional review board worth anything. I have seen perfectly good logistic regression models get tossed because the attending physician could not articulate which variables drove the prediction. Simpler models often win in practice even when they are slightly less accurate, because clinicians need to trust what they are seeing. Data quality is almost always worse than you expect. I once spent three weeks tracking down why a prediction model kept failing on weekends. The issue turned out to be that weekend labs were processed on a different machine with slightly different calibration curves. The model saw systematic shifts and interpreted them as pathological changes. We fixed it by adding a batch effect adjustment, but the lesson was clear: context matters more than the algorithm. There is also the human factor. A quantitative approach can come across as cold or dismissive to colleagues who rely on clinical intuition. I have watched good models die not because they were wrong but because the attending felt threatened by them. The workaround is to involve clinicians from day one, not as end users but as co-designers. The sepsis model would have caught that confounder if the infectious disease attendings had been in the room when we defined the features.

If you are trying to replicate this, start small. Pick one well-defined clinical question. Use publicly available datasets first — MIMIC-IV is the standard for critical care research. Build a simple model. Validate it. Then scale up. Do not start with deep learning. Start with something you can explain in five minutes to a busy attending who does not have time for a tutorial. The approach works when the problem is quantifiable and the data is clean. It breaks down when you are dealing with subjective outcomes, sparse data, or situations where the cost of a false positive is catastrophically different from a false negative. Those edge cases still belong to clinical judgment. The math supplements that judgment. It does not replace it.